• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去甲肾上腺素通过刺激α(1A)-和α(1D)-肾上腺素受体收缩大鼠视网膜小动脉。

Noradrenaline contracts rat retinal arterioles via stimulation of α(1A)- and α(1D)-adrenoceptors.

机构信息

Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.

出版信息

Eur J Pharmacol. 2011 Dec 30;673(1-3):65-9. doi: 10.1016/j.ejphar.2011.10.012. Epub 2011 Oct 21.

DOI:10.1016/j.ejphar.2011.10.012
PMID:22040923
Abstract

The aim of this study was to characterize the α₁-adrenoceptor subtype(s) involved in the noradrenaline-induced contraction of retinal arterioles in rats. In vivo ocular fundus images were captured with a digital camera equipped with a special objective lens. By measuring changes in diameter of retinal arterioles in the fundus images, retinal vascular response was assessed. The systemic blood pressure and heart rate in the animals were also continuously recorded. Following blockade of β₁/β₂-adrenoceptors with propranolol, noradrenaline (0.03-3 μg/kg/min, i.v.) decreased the diameter of retinal arterioles and increased the mean blood pressure in a dose-dependent manner. The highest dose (3 μg/kg/min, i.v.) of noradrenaline caused a small increase in heart rate. The α(1A)-adrenoceptor antagonist RS100329 (0.1 mg/kg, i.v.) and the α(1D)-adrenoceptor antagonist BMY 7378 (1 mg/kg, i.v.) significantly prevented noradrenaline-induced contraction of retinal arterioles and pressor responses whereas the α(1B)-adrenoceptor antagonist L-765314 (1 mg/kg, i.v.) did not. The α(1A)-adrenoceptor agonist, A 61603 (0.03-0.3 μg/kg/min, i.v.), also caused contractile responses of retinal arterioles and pressor responses. These responses were almost completely prevented by RS100329 (0.1 mg/kg, i.v.), but not by BMY 7378 (1 mg/kg, i.v.). These results suggest that the contractile effects of noradrenaline on retinal arterioles and peripheral resistance vessels are, at least in part, mediated by stimulation of α(1A)- and α(1D)-adrenoceptors. Furthermore, it is likely that the α₁-adrenoceptor subtype(s) involved in rat vascular responses are similar in both retinal and peripheral circulation.

摘要

本研究旨在描述参与去甲肾上腺素诱导大鼠视网膜小动脉收缩的 α₁-肾上腺素受体亚型。使用配备特殊物镜的数码相机捕获眼底的活体图像。通过测量眼底图像中视网膜小动脉的直径变化,评估视网膜血管反应。同时连续记录动物的系统血压和心率。在阻断β₁/β₂-肾上腺素受体后,去甲肾上腺素(0.03-3μg/kg/min,静脉内)以剂量依赖性方式降低视网膜小动脉的直径并增加平均血压。最高剂量(3μg/kg/min,静脉内)的去甲肾上腺素引起心率的轻微增加。α(1A)-肾上腺素受体拮抗剂 RS100329(0.1mg/kg,静脉内)和 α(1D)-肾上腺素受体拮抗剂 BMY 7378(1mg/kg,静脉内)显著预防去甲肾上腺素诱导的视网膜小动脉收缩和升压反应,而 α(1B)-肾上腺素受体拮抗剂 L-765314(1mg/kg,静脉内)则没有。α(1A)-肾上腺素受体激动剂 A 61603(0.03-0.3μg/kg/min,静脉内)也引起视网膜小动脉收缩和升压反应。这些反应几乎完全被 RS100329(0.1mg/kg,静脉内)预防,但不能被 BMY 7378(1mg/kg,静脉内)预防。这些结果表明,去甲肾上腺素对视网膜小动脉和外周阻力血管的收缩作用至少部分是通过刺激 α(1A)-和 α(1D)-肾上腺素受体介导的。此外,参与大鼠血管反应的 α₁-肾上腺素受体亚型在视网膜和外周循环中可能相似。

相似文献

1
Noradrenaline contracts rat retinal arterioles via stimulation of α(1A)- and α(1D)-adrenoceptors.去甲肾上腺素通过刺激α(1A)-和α(1D)-肾上腺素受体收缩大鼠视网膜小动脉。
Eur J Pharmacol. 2011 Dec 30;673(1-3):65-9. doi: 10.1016/j.ejphar.2011.10.012. Epub 2011 Oct 21.
2
Role of β3-adrenoceptors in regulation of retinal vascular tone in rats.β3-肾上腺素能受体在大鼠视网膜血管张力调节中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2011 Dec;384(6):603-8. doi: 10.1007/s00210-011-0682-2. Epub 2011 Sep 8.
3
Alpha1-adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries.参与大鼠股部阻力动脉对外源性和神经释放去甲肾上腺素血管收缩反应的α1-肾上腺素能受体亚型。
Br J Pharmacol. 2004 Mar;141(6):915-24. doi: 10.1038/sj.bjp.0705690. Epub 2004 Feb 23.
4
Stimulation of β- and β-adrenoceptors dilates retinal blood vessels in rats.刺激β-肾上腺素能受体和β-肾上腺素受体可使大鼠视网膜血管扩张。
Naunyn Schmiedebergs Arch Pharmacol. 2017 May;390(5):527-533. doi: 10.1007/s00210-017-1349-4. Epub 2017 Feb 3.
5
Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat.育亨宾拮抗α1A-和α1D-肾上腺素受体介导的成分,除了α2A-肾上腺素受体成分,以加压反应在被切断脑的大鼠。
Eur J Pharmacol. 2012 Mar 15;679(1-3):90-4. doi: 10.1016/j.ejphar.2012.01.001. Epub 2012 Jan 21.
6
Existence of different alpha(1)-adrenoceptor subtypes in junctional and extrajunctional neurovascular regions in canine splenic arteries.犬脾动脉交界区和非交界区神经血管区域中不同α(1)-肾上腺素能受体亚型的存在
Br J Pharmacol. 2001 Apr;132(8):1852-8. doi: 10.1038/sj.bjp.0704020.
7
Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats.用野百合碱处理的大鼠α1-肾上腺素能血管反应性的变化。
Naunyn Schmiedebergs Arch Pharmacol. 2002 Feb;365(2):87-95. doi: 10.1007/s00210-001-0515-9. Epub 2001 Dec 20.
8
Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat.大鼠离体尾动脉中介导去甲肾上腺素收缩反应的α1A-肾上腺素能受体的药理学特性
Br J Pharmacol. 1997 Mar;120(5):819-26. doi: 10.1038/sj.bjp.0700983.
9
WAY 405, a new silent 5-HT (1A) receptor antagonist with low affinity for vascular alpha (1)-adrenoceptors.WAY 405,一种对血管α(1)-肾上腺素能受体亲和力低的新型5-羟色胺(1A)受体拮抗剂。
Auton Autacoid Pharmacol. 2005 Oct;25(4):185-9. doi: 10.1111/j.1474-8673.2005.00350.x.
10
Functional subtypes of renal alpha1-adrenoceptor in spontaneously hypertensive rats with streptozotocin-induced experimental diabetic nephropathy.自发性高血压大鼠伴链脲佐菌素诱导的实验性糖尿病肾病肾α1-肾上腺素受体的功能亚型。
Kidney Blood Press Res. 2009;32(5):349-59. doi: 10.1159/000249149. Epub 2009 Oct 20.

引用本文的文献

1
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells.α1D肾上腺素能受体拮抗作用可预防高糖诱导的ARPE-19细胞线粒体功能障碍和血视网膜屏障破坏。
Int J Mol Sci. 2025 Jan 24;26(3):967. doi: 10.3390/ijms26030967.
2
Adrenoceptors in the Eye - Physiological and Pathophysiological Relevance.眼部肾上腺素能受体——生理与病理生理学相关性。
Handb Exp Pharmacol. 2024;285:453-505. doi: 10.1007/164_2023_702.
3
β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases-Historical Aspects and Nowadays Understanding.
β-肾上腺素能受体作为眼部肿瘤和其他眼病的治疗靶点:历史方面和现今的认识。
Int J Mol Sci. 2023 Feb 28;24(5):4698. doi: 10.3390/ijms24054698.
4
The Role of Adrenoceptors in the Retina.肾上腺素受体在视网膜中的作用。
Cells. 2020 Dec 3;9(12):2594. doi: 10.3390/cells9122594.
5
Relationship between plasma levels of vasoactive mediators and optic nerve head circulation shown by laser speckle flowgraphy.激光散斑血流图显示血管活性介质血浆水平与视神经乳头循环之间的关系。
Graefes Arch Clin Exp Ophthalmol. 2016 Jun;254(6):1033-9. doi: 10.1007/s00417-015-3145-5. Epub 2015 Sep 2.
6
The α₁B -adrenoceptor subtype mediates adrenergic vasoconstriction in mouse retinal arterioles with damaged endothelium.α₁B -肾上腺素能受体亚型介导内皮受损的小鼠视网膜小动脉的肾上腺素能血管收缩。
Br J Pharmacol. 2014 Aug;171(16):3858-67. doi: 10.1111/bph.12743.
7
Perivascular innervation: a multiplicity of roles in vasomotor control and myoendothelial signaling.血管周围神经支配:在血管舒缩控制和肌内皮信号传递中的多种作用。
Microcirculation. 2013 Apr;20(3):217-38. doi: 10.1111/micc.12035.